| SZ CAT No: | CL-RTC-02 |
| CAS No: | 425365-64-6 |
| Mol.F: | C42H78N2O16 |
| Mol.Wt.: | 867.1 |
| Chemical Name: | (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-((((2-methoxyethoxy)methoxy)methoxy)imino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one |
| SMILES: | CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N\OCOCOCCOC)/[C@H](C)[C@@H](O)[C@]1(C)O |
| Inventory Status: | Custom synthesis |
This impurity is related to Roxithromycin EP Impurity G is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Roxithromycin EP Impurity G is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-((((2-methoxyethoxy)methoxy)methoxy)imino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-oneCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Roxithromycin Molecular Formula: C42H78N2O16
Molecular Weight: 867.1
Storage: Store in a cool, dry place.
Cat. No: CL-RTC-01
CAS No: 80214-83-1
Mol. F: C41H76N2O15
Mol. Wt: 837.1
Inv. Status: In Stock
Cat. No: CL-RTC-NO-01
CAS No: NA
Mol. F: C40H73N3O16
Mol. Wt: 852.02
Inv. Status: In Stock
Cat. No: CL-RTC-03
CAS No: NA
Mol. F: C41H76N2O16
Mol. Wt: 853.05
Inv. Status: In Stock
Cat. No: CL-RTC-05
CAS No: 13127-18-9
Mol. F: C37H68N2O13
Mol. Wt: 749
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-06
CAS No: 214902-82-6
Mol. F: C33H62N2O12
Mol. Wt: 678.9
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-07
CAS No: 134931-00-3
Mol. F: C41H76N2O15
Mol. Wt: 837.1
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-08
CAS No: 1460313-66-9
Mol. F: C40H74N2O15
Mol. Wt: 823
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-10
CAS No: 425365-65-7
Mol. F: C41H76N2O14
Mol. Wt: 821.1
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-11
CAS No: 425365-66-8
Mol. F: C45H84N2O17
Mol. Wt: 925.2
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-12
CAS No: 134834-12-1
Mol. F: C40H73ClN2O14
Mol. Wt: 841.5
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-13
CAS No: NA
Mol. F: C41H76N2O16
Mol. Wt: 853.1
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-14
CAS No: NA
Mol. F: C41H76N2O16
Mol. Wt: 853.1
Inv. Status: Custom Synthesis
-Roxithromycin D7.jpg)
Cat. No: CL-RTC-15
CAS No: NA
Mol. F: C41H69D7N2O15
Mol. Wt: 844.1
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-16
CAS No: NA
Mol. F: C41H69D7N2O14
Mol. Wt: 828.1
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-17
CAS No: NA
Mol. F: C40H67D7N2O15
Mol. Wt: 830.1
Inv. Status: Custom Synthesis
Cat. No: CL-RTC-18
CAS No: NA
Mol. F: C41H69D7N2O15
Mol. Wt: 844.1
Inv. Status: Custom Synthesis
| CAT No: | CL-RTC-02 |
| CAS No: | 425365-64-6 |
| Mol.F: | C42H78N2O16 |
| Mol.Wt: | 867.1 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: